Investment Summary

Exponent Private Equity Invests In Ethos Engineering

On March 20, 2024, private equity firm Exponent Private Equity invested in engineering company Ethos Engineering

Investment Highlights
  • This is Exponent Private Equity’s 2nd transaction in the Engineering sector.
  • This is Exponent Private Equity’s 5th transaction in Ireland.

Investment Summary

Date 2024-03-20
Target Ethos Engineering
Sector Engineering
Investor(s) Exponent Private Equity
Deal Type Growth Capital
Advisor(s) Capnua (Financial)
Beauchamps (Legal)

Target

Ethos Engineering

Dublin, Ireland
Ethos Engineering delivers high-performance mechanical and electrical (M&E) engineering solutions across Ireland and EMEA. Their expertise spans data centres, commercial, offices, and high-tech environments, with services in design & project management, sustainability, smart buildings, and M&E systems for building services. Ethos Engineering was founded in 2005 and is based in Dublin, Ireland.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Exponent Private Equity

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2004
PE ASSETS 3.8B GBP
Size Large
Type Sector Agnostic
DESCRIPTION

Exponent is a private equity firm focused on acquiring middle-market businesses located in the UK and broader Europe. Exponent targets opportunities in the media, business and financial services, healthcare, consumer, and leisure sectors. The Firm seeks to invest in businesses valued from €150 to €500 million. Exponent has a particular interest in businesses that are prominent in their respective markets, but may benefit from or need operational improvement. Exponent Private Equity was formed in 2004 and is based in London.


DEAL STATS #
Overall 42 of 44
Sector: Engineering M&A 2 of 2
Type: Growth Capital M&A Deals 3 of 3
Country: Ireland M&A 5 of 5
Year: 2024 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-07 Chanelle Pharma

Co Galway, Ireland

Chanelle Pharma is a manufacturer of veterinary and medical generic pharmaceuticals, serving blue-chip customers globally. Chanelle Pharma was founded in 1985 and is based in Co Galway, Ireland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-02 Isio

London, United Kingdom

Isio Group is an independent pensions advice and wealth management specialist that combines actuarial expertise, third-party administration, investment consulting, and DC specialism. Isio was formed in 2019 and is based in London, United Kingdom.

Sell -